Clorazepate monopotassium or potassium clorazepate

This classification denotes a benzodiazepine with the molecular structure C16H10CLN2O3.K, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier, MS63G8NQUI chemically known as 1h-1,4-benzodiazepine-3-carboxylic acid, 7-chloro-2,3-dihydro-2-oxo-5-phenyl-, potassium salt, but more commonly known as clorazepate monopotassium, which bears US NIH Compound Identifier 22312. European Medicines Agency schedules Clorazepate monopotassium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01369MIG. Most nations, for tariff and trade purposes, schedule clorazepate monopotassium under HS 29339100 and SITC 51577. As of Q4 2014, CLORAZEPATE MONOPOTASSIUM remains US FDA's Preferred Term for this commodity. Clorazepate monopotassium bears US NLM identifiers UMLS ID C0009034 and NCI Concept Code C76533. SMILES: C1CCC(CC1)C2=NC(C(=O)NC3C2CC(CC3)CL)C(=O)[O-].[K+].